Max-Planck-Unit for Structural Molecular Biology, Hamburg, Germany.
Neurodegener Dis. 2010;7(1-3):28-31. doi: 10.1159/000283479. Epub 2010 Feb 13.
Aggregates of the tau protein are a hallmark of Alzheimer's and several other neurodegenerative diseases. Various transgenic mouse models have been generated to study the aggregation process. Since wild-type tau is highly soluble and does not aggregate readily, most models make use of tau mutations that occur in human frontotemporal dementias and are more prone to aggregate. These mouse models show neurofibrillary tangles similar to those of Alzheimer's disease. However, since the mice contain both endogenous wild-type mouse tau and exogenous human mutant tau, the relative contribution of these components to the aggregates has been a matter of debate.
Using a new set of regulatable transgenic mouse models, we sought to determine whether mouse tau coaggregates with human tau when it is switched on. Furthermore, we asked what type of tau remains in the aggregates after switching off the expression of exogenous tau.
We generated doxycycline-inducible transgenic mice expressing either full-length human tau or the tau repeat domain (tau(RD)). In addition, both types of human tau derivatives were expressed in a 'proaggregant' form (with the frontotemporal dementia with parkinsonism linked to chromosome 17 mutation DeltaK280), or in an 'antiaggregant' form (with additional proline mutations to block beta-structure and aggregation).
The proaggregant tau(RD) mice develop tangles rapidly after induction, the antiaggregant mice do not. Analysis by biochemistry and immunohistology reveals that the tangles contain both exogenous and endogenous mouse tau. After switching off the proaggregant tau(RD), tangles persist for extended periods. However, they are composed entirely of mouse tau.
Mouse tau and exogenous human tau can coaggregate in transgenic models of tauopathy. The aggregates are in dynamic equilibrium with their subunits, so that exogenous tau disappears when its expression is switched off. Once the seeds of aggregation are generated by the foreign tau species, they propagate in a 'prion-like' fashion within the cell even after the foreign tau has disappeared.
tau 蛋白聚集体是阿尔茨海默病和其他几种神经退行性疾病的标志。已经生成了各种转基因小鼠模型来研究聚集过程。由于野生型 tau 高度可溶且不易聚集,因此大多数模型都利用了在额颞叶痴呆中发生的 tau 突变,这些突变更容易聚集。这些小鼠模型显示出类似于阿尔茨海默病的神经原纤维缠结。然而,由于小鼠同时含有内源性野生型小鼠 tau 和外源性人类突变型 tau,这些成分对聚集体的相对贡献一直存在争议。
使用一组新的可调节转基因小鼠模型,我们试图确定当 tau 被激活时,小鼠 tau 是否与人类 tau 共聚集。此外,我们还询问了在关闭外源性 tau 的表达后,聚集体中还残留哪种类型的 tau。
我们生成了可诱导表达全长人类 tau 或 tau 重复结构域(tau(RD))的两种新的可调节转基因小鼠。此外,这两种人类 tau 衍生物都以“促聚集”形式(具有额颞叶痴呆伴帕金森病与 17 号染色体关联的 DeltaK280 突变)或“抗聚集”形式(具有额外的脯氨酸突变以阻止β-结构和聚集)表达。
促聚集 tau(RD)小鼠在诱导后迅速发展为缠结,抗聚集小鼠则不会。通过生物化学和免疫组织化学分析发现,缠结包含外源性和内源性小鼠 tau。在关闭促聚集 tau(RD)后,缠结会持续很长时间。然而,它们完全由小鼠 tau 组成。
在 tau 病的转基因模型中,小鼠 tau 和外源性人类 tau 可以共聚集。聚集体与其亚单位处于动态平衡中,因此当外源性 tau 的表达被关闭时,它会消失。一旦外源性 tau 物种产生了聚集的种子,它们就会以类似于朊病毒的方式在细胞内传播,即使外源性 tau 已经消失。